this post was submitted on 14 Oct 2025
27 points (100.0% liked)

World News

55306 readers
2035 users here now

A community for discussing events around the World

Rules:

Similarly, if you see posts along these lines, do not engage. Report them, block them, and live a happier life than they do. We see too many slapfights that boil down to "Mom! He's bugging me!" and "I'm not touching you!" Going forward, slapfights will result in removed comments and temp bans to cool off.

We ask that the users report any comment or post that violate the rules, to use critical thinking when reading, posting or commenting. Users that post off-topic spam, advocate violence, have multiple comments or posts removed, weaponize reports or violate the code of conduct will be banned.

All posts and comments will be reviewed on a case-by-case basis. This means that some content that violates the rules may be allowed, while other content that does not violate the rules may be removed. The moderators retain the right to remove any content and ban users.


Lemmy World Partners

News !news@lemmy.world

Politics !politics@lemmy.world

World Politics !globalpolitics@lemmy.world


Recommendations

For Firefox users, there is media bias / propaganda / fact check plugin.

https://addons.mozilla.org/en-US/firefox/addon/media-bias-fact-check/

founded 2 years ago
MODERATORS
 

cross-posted from: https://lemmy.sdf.org/post/44047903

Archived

[...]

Efforts to diversify domestic manufacturing and supply are ongoing, focusing on supporting Polish pharmaceutical companies and building facilities closer to European markets. However, production decisions regarding active pharmaceutical ingredients (APIs) or finished products remain commercial, independently made by responsible entities based on business strategies.

A key ministry goal is to reduce Poland’s reliance on external markets, especially on Asian suppliers responsible for most raw materials and APIs. “Uncoupling from Asia is crucial to enhancing Poland’s supply chain stability,” the ministry noted, highlighting its cooperation with the Government Strategic Reserves Agency (RARS), which plays a vital role in crisis management. RARS maintains expert capacity and logistics, proven during COVID-19 vaccine deployment and aid to Ukraine.

Another key area in Poland’s pharmaceutical security strategy is the National List of Critical Medicines. First presented in December 2024, this list has since been updated to include 401 substances deemed crucial for patient safety and the resilience of the healthcare system.

[...]

“True security lies in producing medicines in the EU and Poland,” [president of Medicines for Poland Krzysztof] Kopeć stressed. While acknowledging the ministry’s National List of Critical Medicines, he emphasised that lists alone don’t guarantee security. Reducing dependence on Asia requires cost acceptance by the EU and national governments. European producers need profitable prices to manufacture medicines sustainably.

[...]

[Michał Byliniak, director general of INFARMA, the Employers' Union of Innovative Pharmaceutical Companies] emphasised the need to ensure patients’ needs are met during armed conflict, with timely access to medicine, even before emergency procedures are activated. “We faced such challenges after the Ukraine war began, guaranteeing treatment continuity for patients who suddenly lost access,” he recalled.

[...]

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here